title: Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.
abstract: 15q13.3 deletion syndrome (15q13.3DS) is a common recurrent genomic disorder associated with epilepsy, intellectual impairment, aggressive behavior, schizophrenia, and autism. A 39-year-old male presented with 15q13.3DS, epilepsy, intellectual impairment, psychosis, and recurrent episodes of aggressive rage. We hypothesized that the patient's aggressive behavior reflected deficits in α7 nicotinic cholinergic receptor (NChR)-mediated neurotransmission, arising from haploinsufficiency of the structural gene CHRNA7 due to the deletion. Treatment with the NChR allosteric modulator and acetylcholinesterase (AChE) inhibitor, galantamine, led to a dramatic decline in the frequency and intensity of rage outbursts, suggesting that enhancement of α7 NChR function can ameliorate 15q13.3DS-associated rage outbursts.
authors: Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA. jcubell@emory.edu
authors: Joseph F
authors: JF
authors: Cubells
authors: Elizabeth H
authors: EH
authors: Deoreo
authors: Philip D
authors: PD
authors: Harvey
authors: Steven J
authors: SJ
authors: Garlow
authors: Kathryn
authors: K
authors: Garber
authors: Margaret P
authors: MP
authors: Adam
authors: Christa Lese
authors: CL
authors: Martin